Klinic can connect you with a provider who can evaluate you for a prescription, and our care team handles insurance verification and prior authorization so you can focus on your health
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Active cardiovascular disease, recent heart attack, or unstable angina
Several major studies reported average body-weight reductions approaching 25-30%, placing Retatrutide among the most promising metabolic peptides currently under investigation
Light activity like walking has no impact on medication absorption